Argentinian healthtech firm Avedian has successfully closed a $2.2 million funding round led by Meet Capital to fuel its global expansion. Founded by three brothers with deep family roots in the healthcare sector, the company develops artificial intelligence to optimize hospital operations. This new capital will enable Avedian to scale its proven technology and bring enhanced efficiency to healthcare systems worldwide.
From Family Roots to a Global Vision
Avedian was founded in 2017 by brothers Guillermo, Pablo, and Facundo Tabares, who represent the third generation of their family in the healthcare industry. Growing up within their family's sanatorium, they gained firsthand knowledge of the clinical and financial inefficiencies plaguing the system. This unique upbringing provided the conviction that technology could unlock significant improvements in patient care and operational management.
AI-Powered Healthcare Optimization
The company's core offerings are two AI-driven platforms, Hosdatia for hospitals and Insuria for insurance providers and funders. These solutions integrate and analyze scattered data from affiliation, auditing, and billing systems to create a unified, intelligent view of operations. By centralizing this information, Avedian provides healthcare administrators with the tools needed for proactive decision-making and resource management.
The impact of Avedian's technology is substantial, with clients reporting up to a 30% increase in hospital bed availability and a 25% reduction in average patient stays. The platforms can also boost revenues by 40% while cutting costs associated with non-quality care by 20%. CEO Guillermo Tabares notes that the AI anticipates complications and personalizes care, allowing health systems to become more efficient.
Strategic Funding for Global Expansion
The recent $2.2 million investment round, led by Meet Capital with support from healthcare-focused angel investors and family offices, marks a pivotal moment for Avedian. This capital is strategically allocated to accelerate the company's growth trajectory. A primary focus will be on expanding the engineering and data science teams to further innovate its AI-powered platforms.
A significant portion of the funds will also be used to strengthen commercial alliances in new international territories. "This round drives us to bring our technology to the world's hospitals," stated CEO Guillermo Tabares. The company's next stage is clearly defined by scaling its operations and demonstrating the measurable, transformative impact of AI in healthcare delivery.
A Proven Track Record and a New Global Horizon
Avedian has already built a solid foundation in Latin America, with operations in five countries and annual revenue exceeding $2 million. Its client roster includes major players like Keralty in Colombia, ARS Primera in the Dominican Republic, and RIMAC Seguros in Peru. This established regional success has validated its business model and prepared the company for its next ambitious chapter.
A landmark global distribution agreement with a prominent U.S. hospital has unlocked access to major international markets. This partnership will introduce Avedian's solutions to over 90 health systems in regions including China, India, Saudi Arabia, and Switzerland. The deal represents a significant step in transforming the Argentinian startup into a global force in health technology.
This latest funding round is more than a financial achievement for Avedian; it is a powerful endorsement of its vision to revolutionize healthcare management. By leveraging its deep industry roots and advanced AI, the company is poised to transition from a Latin American leader to a global innovator. The successful capital raise and strategic partnerships signal the beginning of a new era of data-driven efficiency for hospitals worldwide.